文献速递冠心病外科

心血管疾病家族史与冠状动脉旁路移植术后长期结局:一个遗传悖论?

Positive family history of cardiovascular disease and long-term outcomes after coronary artery bypass grafting: a genetic paradox?
PubMed 文献 · Eur J Cardiothorac Surg · 2020-01-01

该回顾性纵向研究纳入2001至2018年连续招募的5389例CABG患者,其中2535例60岁以下早发心血管疾病患者有父母心血管疾病信息。采用Framingham子代研究标准定义家族史,多变量Cox回归分析显示,阳性家族史与更好的总体生存(校正HR 0.67,95%CI 0.50-0.90;P=0.008)和无主要不良心脑血管事件生存(校正HR 0.73,95%CI 0.68-0.89;P=0.01)相关。

要点

  • 阳性心血管疾病家族史在早发CABG患者中占54.2%。
  • 阳性家族史与术后长期总体生存改善独立相关(校正HR 0.67)。
  • 阳性家族史也与无主要不良心脑血管事件生存改善相关(校正HR 0.73)。

核心结论

  • 尽管阳性家族史已知增加年轻时需行CABG的风险,但本研究显示其 paradoxically 与更好的长期结局相关。

研究设计与样本

  • 回顾性纵向研究,连续招募2001至2018年CABG患者5389例,其中2535例60岁以下早发心血管疾病且有父母心血管疾病信息者纳入分析。
  • 采用Framingham子代研究标准定义阳性家族史,使用多变量Cox比例风险回归模型评估家族史对总体生存和无主要不良心脑血管事件生存的影响。

主要发现

  • 随访期间共发生273例死亡和428例主要不良心脑血管事件。
  • 阳性家族史见于54.2%(n=1375)的患者,其中66.1%父亲有早发心血管事件(n=909),27.8%母亲(n=382),6.1%父母双方(n=84)。
  • 85.9%(n=1181)的阳性家族史患者父母有心脏事件,14.1%(n=194)报告父母卒中。
  • 阳性家族史与改善的总体生存相关(校正HR 0.67,95%CI 0.50-0.90;P=0.008)。
  • 阳性家族史与改善的无主要不良心脑血管事件生存相关(校正HR 0.73,95%CI 0.68-0.89;P=0.01)。

关键数值与推荐

  • 阳性家族史定义采用Framingham子代研究标准。
  • 年龄、糖尿病、肾功能不全、外周动脉疾病、射血分数、既往脑血管事件和既往纵隔放疗均与更差结局相关。

临床怎么用

  • 对于早发心血管疾病行CABG的患者,阳性家族史不应被视为不良预后的标志,反而可能提示更好的长期结局。
  • 临床风险评估中可将家族史作为独立因素考虑,但需结合其他 covariates 综合判断。

局限性

  • 回顾性研究设计。
  • 仅纳入60岁以下早发心血管疾病患者,结果可能不适用于其他人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Parental cardiovascular disease (CVD) is a known risk factor for premature CVD. It is unknown whether a positive family history (PFH) affects outcomes after coronary artery bypass grafting (CABG). METHODS: Data come from a retrospective longitudinal study of CABG patients consecutively recruited from 2001 to 2018 (n = 5389). From this study, 2535 patients with premature CVD undergoing CABG under the age of 60 years and information on parental CVD were identified. The Framingham offspring study criteria were used to identify PFH of CVD. Multivariable Cox proportional hazards regression models were used to assess the effect of PFH on overall and major adverse cardiovascular and cerebrovascular event-free survival. RESULTS: A total of 273 deaths and 428 major adverse cardiovascular and cerebrovascular events occurred during follow-up. PFH of CVD was found in 54.2% of patients (n = 1375). Within these patients, 66.1% had a father who experienced a premature cardiovascular event (n = 909), 27.8% a mother (n = 382) and 6.1% both a mother and a father (n = 84). In the majority of cases, the patient's parent had experienced a cardiac event (85.9%, n = 1181) and 14.1% of patients with PFH reported parental stroke (n = 194). Following CABG, PFH was associated with improved overall [adjusted hazards ratio (HR) 0.67, 95% confidence interval (CI) 0.50-0.90; P = 0.008] and major adverse cardiovascular and cerebrovascular event-free survival (adjusted HR 0.73, 95% CI 0.68-0.89; P = 0.01). Among the covariates adjusted for age, diabetes, renal insufficiency, peripheral arterial disease, ejection fraction, previous cerebrovascular events and previous mediastinal radiation were all associated with poorer outcomes. CONCLUSIONS: Although it is well established that a PFH increases the risk of requiring CABG at younger ages, this study shows that, paradoxically, PFH is also protective regarding long-term outcomes. REGISTRATION NUMBER LOCAL IRB: UN4232 297/4.3 (retrospective study).

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Ruttmann E, Abfalterer H, Dietl M, et al. Positive family history of cardiovascular disease and long-term outcomes after coronary artery bypass grafting: a genetic paradox? Eur J Cardiothorac Surg. 2020. PMID: 31819982. doi:10.1093/ejcts/ezz333

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。